A strong stock as of late has been Archer Daniels Midland (ADM) . Shares have been marching higher, with the stock up 2.6% over the past month. The stock hit a new 52-week high of $74.89 in the previous session. ADM has gained 29.2% since the start of the year compared to the 3.7% move for the Zacks Consumer Staples sector and the 18.7% return for the Zacks Agriculture - Operations industry. What's Driving the Outperformance? The stock has an impressive record of positive earnings surprises, having beaten t ...

Dutch Bros (BROS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares of this drive-thru coffee chain operator and franchisor have returned +9.5% over the past month versus the Zacks S&P 500 composite's +12.2% change. The Zacks Retail - Restaurants industry, to which Dutch Bros belongs, has gained 4.4% over this period. Now the key question is: Where could the stock be heade ...

Boston Scientific (BSX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future. Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is high ...

Workday (WDAY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this maker of human resources software have returned -5.1% over the past month versus the Zacks S&P 500 composite's +12.2% change. The Zacks Internet - Software industry, to which Workday belongs, has gained 16.5% over this period. Now the key question is: Where could the stock be headed in the near term? Althoug ...

Oscar Health, Inc. (OSCR) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future. Shares of this company have returned +52.9% over the past month versus the Zacks S&P 500 composite's +12.2% change. The Zacks Insurance - Multi line industry, to which Oscar Health belongs, has gained 8.4% over this period. Now the key question is: Where could the stock be headed in the near ...

Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. If you are interested in keeping up to date with stocks making moves within the biotech, pharma, and ...

公司与行业动态 - Peloton Interactive 与 Spotify Technology 达成全球合作 将超过1400节Peloton健身课程直接整合至Spotify音频流媒体应用 为Spotify高级订阅用户提供服务[1] - 此次合作旨在将Spotify转变为健康中心[1] - 2026年两家公司均面临压力 Spotify股价较年内高点下跌约17% Peloton股价跌幅更深达24%[1] 财务与估值比较 - 从估值角度看 Spotify股票更具吸引力 其远期市盈率约为32倍 而Peloton的远期市盈率接近37倍[2] - Spotify第一季度财务表现支持其估值 每股收益为3.45欧元 优于预期[2] - Peloton则处于盈利初期阶段 预计5月7日公布的第三季度每股收益为0.06美元[3] - Spotify通过进入有声读物及互动健身等高利润率垂直领域 加强了其实现持续盈利的路径[3] 业务表现与增长前景 - Spotify用户增长迅速 第一季度高级会员数量同比增长9%[4] - 公司预计到2026年底将拥有2.99亿高级订阅用户[4] - 相比之下 Peloton在最近报告的季度末拥有580万订阅用户 同比下降近6.5%[4] - 多元化的收入来源和巨大的数据优势 使Spotify成为2026年风险更低、回报更高的选择[3] 股东回报与市场技术指标 - Spotify近期宣布了一项大规模的股票回购计划 以强化其创造股东价值的重点[5] - Peloton目前没有类似的举措[5] - 从技术分析角度看 Peloton的相对强弱指数目前处于60多的高位 表明其股票即将进入“超买”区域[5] 市场机构观点 - 华尔街机构对Peloton和Spotify股票未来12个月的前景均相当看好[6]

股票近期表现与市场关注度 - 公司股票近期成为Zacks.com上搜索量最高的股票之一，市场关注度较高 [1] - 过去一个月，公司股价回报率为+4.3%，同期标普500指数回报率为+9.3%，公司所属的Zacks零售-家居装饰行业指数涨幅为4.5%，公司股价表现落后于大盘，但基本与行业持平 [2] 盈利预测与评级 - 当前季度，市场一致预期每股收益为2.96美元，较上年同期增长+1.4%，该预期在过去30天内未作修正 [5] - 当前财年，市场一致预期每股收益为12.69美元，较上一财年增长+3.3%，该预期在过去30天内未作修正 [5] - 下一财年，市场一致预期每股收益为13.8美元，较当前财年预期增长+8.7%，该预期在过去30天内未作修正 [6] - 基于近期一致预期的变化及其他相关因素，公司被给予Zacks Rank 4（卖出）评级 [7] 营收增长预测 - 当前季度，市场一致预期营收为229.1亿美元，同比增长+9.5% [11] - 当前财年，市场一致预期营收为933.1亿美元，同比增长+8.1% [11] - 下一财年，市场一致预期营收为966亿美元，同比增长+3.5% [11] 最近财报与历史表现 - 上一报告季度，公司实现营收205.8亿美元，同比增长+10.9% [12] - 上一报告季度，公司实现每股收益1.98美元，上年同期为1.93美元 [12] - 上一报告季度，公司营收超出市场一致预期（203.6亿美元）达+1.08%，每股收益超出预期达+1.54% [12] - 在过去的四个季度中，公司每个季度的每股收益均超出市场预期，营收有两次超出市场预期 [13] 估值水平 - 公司的Zacks价值风格得分为D级，表明其交易价格相对于同业公司存在溢价 [17]

核心观点 - 文章核心观点认为 尽管TJX公司股价在过去十年取得了显著增长且当前估值高于历史水平 但其业务模式稳健 增长前景明确 在当前估值下仍可能代表一个有吸引力的买入机会 投资者不应仅因过往涨幅而回避或买入 而应关注公司长期基本面和未来潜力 [1][7] 业务模式与竞争优势 - TJX公司旗下品牌（如TJ Maxx, Marshalls, HomeGoods）通过以比全价零售低20%至60%的折扣销售商品来吸引客户 [3] - 其商业模式的核心是机会性地从批发商处购买过剩库存 从而实现低价采购 [3] - 在经济困难时期 该模式更具优势 因为公司能以更具吸引力的价格采购更多库存 [4] - 在消费者面临持续高通胀等挑战的经济环境下 许多零售商销售增长乏力 但TJX公司仍能持续发展 [4] 财务与运营表现 - 在截至1月31日的财年 公司所有业务部门都实现了同店销售额（comps）正增长 2026财年同店销售额增长5% 上年同期增长为4% [5] - 管理层预计本财年同店销售额将增长2%至3% [5] - 公司仍在进行国内和国际扩张 去年净增129家门店 年末门店总数达到5,214家 [6] - 公司毛利率为31.10% 股息收益率为1.08% [2] 估值分析 - 公司股票当前市盈率（P/E）为32倍 略高于标普500指数的31倍 [6] - 当前估值高于其10年历史市盈率中位数19倍 [7] - 尽管估值较历史水平更高 但考虑到其持续的增长和执行能力 以及估值与整体市场水平基本相当 文章认为其估值仍属合理 [6][7] - 公司市值为1740亿美元 [2] 历史股价表现 - 截至4月22日 公司股价在过去十年间上涨了312.3% 显著跑赢了同期标普500指数239.4%的涨幅 [1]

Top-notch companies don't often come cheap. Zoetis (ZTS +0.70%) is one of the world's leading animal healthcare companies. The stock has traded at an average price-to-earnings ratio of nearly 39 over the past decade, a lofty premium to the broader market.Today, Zoetis stock trades at just 19 times earnings, its lowest valuation since the stock began trading. Stock prices routinely fluctuate, but such a stark departure from long-term trends warrants a closer look at the business. Here's why Zoetis has slippe ...